We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
-2.88%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$242M
AUM Growth
+$8.86M
Cap. Flow
+$14.9M
Cap. Flow %
6.16%
Top 10 Hldgs %
34.33%
Holding
60
New
15
Increased
15
Reduced
14
Closed
11

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$5.74M
2
CI icon
Cigna
CI
+$4.68M
3
NVO
Novo Nordisk
NVO
+$4.62M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$4.62M
5
MDT icon
Medtronic
MDT
+$3.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$5.91M
2
LLY icon
Eli Lilly
LLY
+$4.5M
3
BDX icon
Becton Dickinson
BDX
+$4.4M
4
BMY icon
Bristol-Myers Squibb
BMY
+$4.37M
5
MOH icon
Molina Healthcare
MOH
+$3.98M

Sector Composition

Rank Sector Weight
1 Healthcare 93.04%
2 Energy 1.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
1
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$13.5M 5.57%
150,000
+50,000
+50% +$4.62M
BSX icon
2
Boston Scientific
BSX
$71.5B
$8.86M 3.66%
200,000
+40,000
+25% +$1.73M
UNH icon
3
UnitedHealth
UNH
$370B
$8.67M 3.58%
17,000
-500
-3% -$241K
DHR icon
4
Danaher
DHR
$144B
$8.07M 3.33%
31,020
+2,820
+10% +$706K
HUM icon
5
Humana
HUM
$46.2B
$7.83M 3.23%
18,000
+500
+3% +$209K
THC icon
6
Tenet Healthcare
THC
$21.1B
$7.74M 3.19%
90,000
– –
TMO icon
7
Thermo Fisher Scientific
TMO
$220B
$7.38M 3.05%
12,500
– –
ELV icon
8
Elevance Health
ELV
$85.5B
$7.37M 3.04%
15,000
-2,500
-14% -$1.14M
MCK icon
9
McKesson
MCK
$101B
$6.89M 2.84%
22,500
-12,500
-36% -$3.4M
UHS icon
10
Universal Health Services
UHS
$10.5B
$6.88M 2.84%
47,500
-12,500
-21% -$1.73M
ISRG icon
11
Intuitive Surgical
ISRG
$134B
$6.79M 2.8%
22,500
+12,301
+121% +$3.59M
JNJ icon
12
Johnson & Johnson
JNJ
$625B
$6.2M 2.56%
35,000
+5,000
+17% +$851K
COR icon
13
Cencora
COR
$61.2B
$6.19M 2.55%
40,000
-12,500
-24% -$1.77M
AVTR icon
14
Avantor
AVTR
$9.19B
$6.09M 2.51%
180,000
– –
CVS icon
15
CVS Health
CVS
$122B
$6.07M 2.51%
60,000
+10,000
+20% +$1.05M
CNC icon
16
Centene
CNC
$32.5B
$5.89M 2.43%
+70,000
New +$5.74M
EHC icon
17
Encompass Health
EHC
$12.4B
$5.86M 2.42%
103,567
+65,857
+175% +$3.44M
CRL icon
18
Charles River Laboratories
CRL
$12.8B
$5.68M 2.34%
20,000
+5,000
+33% +$1.54M
HCA icon
19
HCA Healthcare
HCA
$89.5B
$5.64M 2.33%
22,500
-4,487
-17% -$1.13M
SYK icon
20
Stryker
SYK
$130B
$5.35M 2.21%
20,000
+7,500
+60% +$1.94M
ABT icon
21
Abbott
ABT
$187B
$5.33M 2.2%
45,000
-5,000
-10% -$620K
LH icon
22
Labcorp
LH
$25.9B
$5.27M 2.18%
23,280
-2,910
-11% -$684K
ZBH icon
23
Zimmer Biomet
ZBH
$18.4B
$5.12M 2.11%
40,000
-3,775
-9% -$455K
NVO
24
Novo Nordisk
NVO
$209B
$5M 2.06%
+90,000
New +$4.62M
GMED icon
25
Globus Medical
GMED
$11.2B
$4.8M 1.98%
65,000
-10,000
-13% -$695K
1
2 3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
A
AFBI Miami Beach, Florida $131M AUM
SPWM
Schrum Private Wealth Management St. Augustine, Florida $131M AUM 18.38% 1-Year Est. Return

Sivik Global Healthcare's Q1 2022 Portfolio in Review

As of Q1 2022, Sivik Global Healthcare held 60 positions worth $242M, up 3.8% from $233M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Sivik Global Healthcare deployed $14.9M of net new capital in Q1 2022, opening 15 new positions and adding to 15 existing holdings. Its largest new stake was Centene: 70,000 shares worth $5.89M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 95% a quarter earlier, followed by Energy.

On the sell side, the largest reduction was Eli Lilly, an estimated $4.5M trimmed.

  • Sivik Global Healthcare's largest Q1 2022 buy was Centene: 70,000 shares worth $5.89M.
  • Sivik Global Healthcare added most to State Street SPDR S&P Biotech ETF in Q1 2022, an estimated $4.62M increase.
  • Sivik Global Healthcare's biggest Q1 2022 reduction was Eli Lilly, cutting an estimated $4.5M.
  • Sivik Global Healthcare fully exited Pfizer in Q1 2022, selling an estimated $5.91M.
  • Sivik Global Healthcare's ten largest holdings make up 34% of its $242M portfolio in Q1 2022.
  • Sivik Global Healthcare opened 15 new positions and closed 11 in Q1 2022.
  • Sivik Global Healthcare's portfolio value rose 3.8% quarter-over-quarter to $242M.

Based on Sivik Global Healthcare's 13F filing for Q1 2022, filed 9 May 2022.